['arthritis, rheumatoid']
['enbrel', 'lbec0101']

        Inclusion Criteria:

          -  Male or Female patients from 20 years to 75 years of age when signing Informed
             Consent.

          -  Diagnosed as having RA according to the revised 1987 ACR criteria for at least 6
             months prior to screening

          -  Patients who have inadequate response to MTX administered for at least 12 weeks before
             the beginning of screening period and on a stable dose.

        Exclusion Criteria:

          -  patients with active tuberculosis or latent tuberculosis based on current clinical
             symptoms, chest X-ray test and IFN-γ release assay at screening

          -  patients with any of the following concomitant diseases and/or history within 24 weeks
             before the first administration of investigational products in this study; Serious
             infectious disease, Opportunistic infection, Chronic or recurrent infectious disease

          -  patients with any seropositive result for hepatitis B or hepatitis C or HIV

          -  patients who have any of the following diseases; Sepsis, Demyelinating disorders,
             Lymphoproliferative disease, Infection with prosthetic joint, Autoimmune diseases
             other than rheumatoid arthritis
      